viral
infect
respiratori
tract
common
event
age
group
lead
caus
mortal
children
year
age
develop
countri
infect
caus
signific
econom
burden
estim
direct
indirect
medic
cost
us
exceed
billion
annual
children
age
averag
incid
rate
four
six
viral
respiratori
infectionsyear
rate
gradual
decreas
one
twoyear
adult
respiratori
virus
spread
mainli
direct
contact
infect
individu
predominantli
respiratori
droplet
respiratori
infect
tend
present
throughout
year
warmer
area
temper
climat
seen
often
winter
month
see
fig
although
new
emerg
infect
may
aris
anim
host
major
respiratori
viral
infect
spread
human
ill
introduc
famili
young
schoolag
children
caregiv
secondari
infect
occur
follow
initi
case
respiratori
infect
caus
virus
transmit
primarili
droplet
virus
attach
upper
lower
respiratori
tract
induc
igamedi
immun
respons
mucou
secret
respiratori
tract
iggmedi
respons
serum
respiratori
viral
infect
gener
induc
adapt
immun
respons
protect
howev
repeat
respiratori
infect
due
larg
number
serotyp
viru
antigen
variat
virus
influenza
viru
abil
induc
similar
nonspecif
clinic
sign
clinic
present
respiratori
virus
vari
howev
clinic
symptom
often
similar
tabl
describ
common
clinic
present
virus
caus
respiratori
virus
may
identifiedus
viral
cultur
rapid
test
identifi
antibodi
viru
viral
cultur
reserv
primarili
research
purpos
given
time
cultur
growth
cost
often
rel
low
sensit
clinic
diagnosi
respiratori
viral
infect
remain
standard
clinic
practic
rapid
test
use
frequent
clinic
set
identifi
influenza
rsv
infect
initi
target
treatment
howev
rapid
viru
detect
reduc
antibiot
use
cost
laboratori
test
increasingli
use
differenti
viral
bacteri
infect
sinc
earli
use
antibiot
may
advantag
latter
c
reactiv
protein
crp
procalcitonin
level
blood
two
test
use
procalcitoninguid
treatment
algorithm
shown
decreas
antibiot
use
crp
neither
specif
sensit
enough
differenti
bacteri
respiratori
infect
one
caus
viru
common
cold
acut
infect
upper
respiratori
tract
usual
selflimit
frequent
human
infect
one
billion
cold
everi
year
unit
state
estim
common
cold
result
million
day
absenc
work
million
day
absenc
school
year
typic
common
cold
symptom
consist
nasal
congest
discharg
sore
throat
cough
sneez
sometim
headach
symptom
usual
last
less
day
durat
symptom
fairli
nonspecif
easili
confus
allergi
earli
symptom
seriou
diseas
howev
take
detail
histori
particularli
identifi
sick
contact
usual
help
distinguish
common
cold
ill
although
numer
virus
identifi
etiolog
common
cold
see
tabl
viral
preval
ill
present
rhinovirus
far
common
virus
detect
across
age
group
set
common
cold
symptom
account
case
coronavirus
account
cold
case
influenza
virus
detect
time
given
cold
virus
respiratori
syncyti
viru
also
respons
mani
flulik
ill
signific
overlap
viral
etiolog
common
cold
flu
syndrom
rhinoviru
infect
typic
begin
sore
throat
soon
follow
nasal
congest
rhinorrhea
cough
sneez
ill
progress
sore
throat
symptom
tend
resolv
quickli
initi
wateri
rhinorrhea
becom
increasingli
purul
fever
uncommon
among
adult
cold
frequent
children
viral
respiratori
infect
common
cold
symptom
peak
sever
within
day
onset
mean
durat
day
diagnosi
common
cold
primarili
base
clinic
symptom
alon
often
correctli
made
adult
patient
diagnosi
children
infant
difficult
especi
earli
cours
febril
ill
streptococc
pharyng
resembl
earli
common
cold
symptom
nasal
congest
drainag
usual
seen
common
cold
atyp
streptococc
pharyng
given
wide
rang
overlap
symptom
caus
differ
respiratori
virus
influenza
includ
often
imposs
identifi
specif
viral
etiolog
cold
symptom
particular
patient
although
rapid
detect
viral
pathogen
realtim
polymeras
chain
reaction
increas
diagnost
accuraci
shown
reduc
antibiot
use
cost
therefor
limit
use
everyday
clinic
practic
approach
treatment
common
cold
focus
symptomat
relief
well
prevent
antibiot
ineffect
inappropri
treatment
common
cold
avoid
adult
children
counter
cough
cold
medic
avoid
children
younger
year
due
potenti
harm
lack
benefit
product
shown
improv
cold
symptom
children
includ
vapor
rub
zinc
sulfat
extract
buckwheat
honey
although
qualiti
evid
vari
ineffect
treatment
children
includ
inhal
oral
corticosteroid
echinacea
among
adult
decongest
antihistaminedecongest
combin
intranas
ipratropium
shown
improv
cold
symptom
addit
nonsteroid
antiinflammatori
drug
shown
reliev
discomfort
due
cold
improv
respiratori
symptom
taken
within
h
symptom
onset
zinc
shown
reduc
durat
common
cold
symptom
healthi
adult
plant
prepar
proven
effect
treat
common
cold
among
adult
supplement
trial
regular
use
vitamin
c
decreas
incid
common
cold
posit
effect
symptom
durat
sever
therapeut
trial
vitamin
c
cold
shown
signific
effect
common
cold
symptom
reduct
may
worth
consid
individu
case
given
favor
safeti
profil
low
cost
inflamm
larynx
caus
varieti
condit
includ
viral
bacteri
infect
acid
reflux
voic
misus
overus
toxic
inhal
ingest
postnas
drainag
cough
caus
acut
laryng
defin
inflamm
larynx
vocal
cord
last
less
week
one
common
disord
larynx
symptom
includ
lower
normal
pitch
voic
hoars
usual
last
day
symptom
upper
respiratori
infect
common
along
laryng
condit
link
chang
weather
although
acut
laryng
usual
caus
viral
infect
use
clinic
criteria
distinguish
viral
bacteri
caus
viral
laryng
like
caus
virus
common
cold
ie
rhinoviru
coronaviru
treatment
larg
support
includ
voic
rest
corticosteroid
proton
pump
inhibitor
antibiot
often
prescrib
acut
laryng
howev
recent
systemat
review
conclud
antibiot
benefit
treatment
acut
laryng
influenza
acut
respiratori
ill
caus
influenza
viru
temper
climat
season
epidem
influenza
occur
annual
winter
month
tropic
climat
influenza
case
occur
intermitt
throughout
year
worldwid
three
five
million
peopl
develop
influenza
year
approxim
die
influenzarel
ill
epidemiolog
prevent
branch
influenza
divis
center
diseas
control
prevent
cdc
track
report
influenza
activ
unit
state
weekli
report
throughout
influenza
season
usa
influenza
peak
colder
weather
month
peak
occur
februari
see
fig
influenza
result
signific
econom
cost
well
morbid
mortal
usa
estim
death
attribut
influenza
rang
per
year
major
death
occur
age
year
influenza
viru
singl
strand
rna
viru
orthomyxovirida
famili
come
three
subtyp
b
c
human
influenza
viru
type
b
caus
epidem
human
diseas
influenza
viru
type
c
caus
mild
respiratori
ill
similar
common
cold
influenza
viru
classifi
type
surfac
hemagglutinin
h
neuraminidas
n
antigen
express
appear
new
combin
h
n
antigen
result
antigen
shift
potenti
caus
pandem
human
ill
due
lack
preexist
immun
within
last
decad
two
new
strain
influenza
emerg
result
pandem
strain
mexico
strain
china
vaccin
prefer
public
health
method
prevent
influenza
inactiv
influenza
vaccin
iiv
live
attenu
influenza
vaccin
laiv
avail
season
creat
circul
influenza
b
viru
isol
anticip
circul
follow
season
accord
recommend
world
health
organ
current
recommend
call
annual
influenza
vaccin
individu
greater
month
age
laiv
recommend
iiv
children
age
immedi
avail
child
contraind
live
attenu
vaccin
vaccin
suppli
limit
prefer
given
higher
risk
includ
children
age
month
adult
year
age
immunosuppress
sever
chronic
diseas
includ
morbid
obes
women
becom
pregnant
influenza
season
resid
longterm
care
facil
nativ
americansn
alaskan
time
vaccin
demonstr
minim
effect
symptomat
influenza
otherwis
healthi
adult
one
case
prevent
everi
adult
vaccin
howev
univers
vaccin
encourag
improv
herd
immun
influenza
thu
protect
highrisk
individu
certain
situat
antivir
medic
oseltamivir
zanamivir
use
adjunct
vaccin
prevent
influenza
metaanalysi
prophylaxi
trial
medic
demonstr
signific
reduct
risk
symptomat
influenza
individu
household
howev
due
concern
increas
viral
resist
cdc
recommend
routin
use
chemoprophylaxi
prevent
influenza
rather
recommend
judici
use
known
exposur
high
risk
influenza
complic
influenza
vaccin
contraind
infect
respiratori
tract
influenza
viru
classic
result
acut
onset
system
respiratori
symptom
fever
cough
sore
throat
nasal
congest
headach
myalgia
malais
howev
infect
influenza
viru
asymptomat
caus
syndrom
common
cold
pharyng
pneumonia
virus
respiratori
syncyti
viru
adenoviru
coronaviru
also
caus
influenzalik
ill
major
get
influenza
recov
within
day
cough
fatigu
may
persist
beyond
week
develop
complic
pneumonia
either
viral
secondari
bacteri
infect
life
threaten
particularli
high
risk
influenza
infect
also
exacerb
underli
chronic
diseas
asthma
copd
congest
heart
failur
influenza
suspect
clinic
patient
would
benefit
antivir
treatment
see
presumpt
clinic
diagnosi
influenza
sought
revers
transcriptas
polymeras
chain
reaction
rtpcr
sensit
specif
method
influenza
diagnosi
accord
infecti
diseas
societi
america
howev
test
slow
often
take
sever
day
definit
result
rapid
influenza
diagnost
test
ridt
antigen
test
result
often
avail
quickli
enough
clinic
relev
howev
result
poor
sensit
metaanalysi
studi
ridt
compar
rtpcr
viral
cultur
ridt
demonstr
pool
sensit
ci
pool
specif
ci
reason
posit
ridt
result
consid
adequ
make
diagnosi
neg
ridt
result
use
exclud
diagnosi
influenza
clinic
suspect
four
pharmacolog
agent
avail
treat
influenza
unit
state
neuraminidas
inhibitor
zanamivir
oseltamivir
adamantan
amantadin
rimantadin
amantadin
rimantadin
effect
influenza
due
high
rate
resist
influenza
use
current
recommend
zanamivir
inhal
oseltamivir
oral
effect
influenza
b
still
demonstr
low
rate
resist
treatment
one
agent
recommend
soon
possibl
patient
known
suspect
influenza
hospit
manifest
sever
complic
progress
ill
high
risk
complic
includ
adult
year
age
children
year
age
person
sever
underli
chronic
ill
immunosuppress
sever
high
risk
group
tabl
one
recent
metaanalysi
demonstr
small
nonspecif
effect
reduc
total
durat
influenza
symptom
without
demonstr
reduct
complic
otherwis
healthi
adult
influenza
treat
oseltamivir
zanamivir
use
neuraminidas
inhibitor
treatment
proven
suspect
influenza
otherwis
healthi
adult
without
risk
factor
sever
diseas
determin
clinic
judgment
share
decis
make
acut
bronchiti
selflimit
infect
epitheli
cell
bronchi
character
presenc
cough
without
sputum
product
symptom
acut
bronchiti
overlap
clinic
syndrom
upper
lower
respiratori
tract
infect
symptom
gener
last
week
associ
cough
may
persist
week
usa
acut
bronchiti
ninth
commonli
encount
diagnosi
outpati
set
major
case
uncompl
acut
bronchiti
due
viral
infect
influenza
b
virus
parainfluenza
viru
respiratori
syncyti
viru
coronaviru
adenoviru
rhinoviru
human
metapneumoviru
identifi
though
major
case
caus
agent
isol
mycoplasma
pneumonia
chlamydophila
chlamydia
pneumonia
caus
acut
bronchiti
approxim
adult
case
though
pneumoniacaus
pathogen
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
sometim
isol
patient
acut
bronchiti
role
unclear
appear
etiolog
agent
bronchiti
otherwis
healthi
adult
diagnosi
acut
bronchiti
base
clinic
evid
lower
respiratori
tract
infect
cough
persist
least
day
without
evid
pneumonia
absenc
abnorm
vital
sign
physic
exam
find
consist
pneumonia
chest
radiograph
necessari
unless
patient
elderli
otherwis
immun
suppress
altern
diagnos
asthma
pharyng
sinus
influenza
pertussi
rule
clinic
appropri
antibiot
treatment
acut
uncompl
bronchiti
recommend
systemat
review
avail
evid
demonstr
though
may
modest
reduct
durat
coughrel
symptom
unlik
clinic
signific
overal
benefit
use
antibiot
acut
bronchiti
otherwis
healthi
individu
unless
clinic
suspicion
pertussi
etiolog
agent
clinic
judgment
guid
determin
antibiot
use
elderli
chronic
respiratori
comorbid
spite
recommend
approxim
two
third
patient
acut
bronchiti
prescrib
antibiot
unit
state
procalcitoninguid
therapi
shown
safe
reduc
antibiot
use
lower
respiratori
tract
infect
includ
pneumonia
asthma
copd
uncompl
acut
bronchiti
primari
care
set
help
guid
treatment
bacteri
infect
concern
children
tend
episod
respiratori
infect
adult
mani
infectionsyear
children
may
infect
year
children
attend
daycar
respiratori
infect
major
infect
children
selflimit
support
care
treatment
requir
viral
respiratori
infect
particularli
concern
elderli
immunocompromis
secondari
infect
includ
pneumonia
sepsi
caus
increas
morbid
mortal
popul
allcaus
mortal
also
increas
influenza
popul
among
institution
elderli
respiratori
syncyti
viru
rsv
parainfluenza
influenza
import
caus
respiratori
ill
along
respiratori
precaut
hand
hygien
increas
effort
toward
immun
elderli
caregiv
import
decreas
morbid
popul
eas
travel
interdepend
market
brought
new
challeng
spread
infecti
pathogen
context
practic
physician
awar
grow
threat
emerg
respiratori
infect
pandem
potenti
sever
acut
respiratori
syndromecoronaviru
sarscov
avian
influenza
virus
swineorigin
influenza
human
middl
east
respiratori
syndromecoronaviru
merscov
virus
concern
rel
high
mortal
rate
potenti
result
pandem
zoonot
affect
lower
respiratori
tract
high
morbid
mortal
rate
effect
method
prevent
emerg
virus
time
includ
scrupul
adher
respiratori
precaut
awar
region
spread
outbreak
respiratori
viral
infect
predominantli
transmit
infect
droplet
follow
gener
hygien
practic
help
decreas
transmiss
includ
regular
hand
hygien
minim
contact
sick
individu
avoid
share
person
item
follow
cough
etiquett
includ
cover
nose
mouth
tissu
cough
proper
dispos
tissu
prompt
hand
wash
also
shown
decreas
spread
respiratori
infect
current
effect
vaccin
avail
influenza
measur
prevent
includ
antivir
close
contact
influenza
use
palivizumab
monoclon
antibodi
highrisk
individu
prevent
respiratori
syncyti
viru
rsv
infect
antibiot
resist
healthcar
set
grow
threat
public
health
two
million
peopl
becom
infect
peopl
die
year
antibioticresist
infect
part
antibioticresist
infect
stem
prescrib
antibiot
need
case
viral
respiratori
tract
infect
avoid
inappropri
use
antibiot
viral
infect
physician
strive
adher
clinic
guidelin
decisionsupport
tool
combin
laboratori
test
indic
determin
risk
bacteri
infect
commonli
patient
parent
request
antibiot
viral
infect
physician
feel
pressur
prescrib
antibiot
address
social
stressor
school
work
absenc
situat
famili
doctor
need
clearli
commun
treat
viral
infect
antibiot
ineffect
may
harm
addit
point
neg
reassur
find
exam
give
specif
diagnosi
viral
pharyng
viral
upper
respiratori
infect
instead
viru
help
counsel
patient
lastli
import
acknowledg
suffer
discomfort
caus
viral
infect
proactiv
offer
treatment
symptom
outlin
normal
cours
ill
clear
indic
followup
symptom
resolv
within
expect
timefram
